Trial intelligence / Profile preview

Baimai Ointment for diabetic distal symmetric polyneuropathy

ChiCTR2000036681Phase 4Recruiting

Sponsor
Xuanwu Hospital
Start
Sep 2020
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of Baimai in diabetic peripheral polyneuropathy (DPN) (4 arms), sponsored by Xuanwu Hospital. Primary endpoint: Change in total Michigan Diabetic Neuropathy Score. Started Sep 2020; status: recruiting.

02

Drugs

Baimai
03

Conditions

diabetic peripheral polyneuropathy (DPN)

Beyond the preview

Go deeper on ChiCTR2000036681.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000036681.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call